Search Orphan Drug Designations and Approvals
-
Generic Name: | avelumab |
---|---|
Date Designated: | 10/11/2017 |
Orphan Designation: | Treatment of gastric cancer (GC) including cancer of the gastroesophageal junction (GEJ) |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
EMD Serono Research & Development Institute, Inc. 45A Middlesex Turnpike Billerica, Massachusetts 01821 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-